nodes	percent_of_prediction	percent_of_DWPC	metapath
Bicalutamide—Hypochromic anaemia—Octreotide—thymus cancer	0.0372	0.0372	CcSEcCtD
Bicalutamide—Prostatic disorder—Octreotide—thymus cancer	0.034	0.034	CcSEcCtD
Bicalutamide—Hernia—Octreotide—thymus cancer	0.0308	0.0308	CcSEcCtD
Bicalutamide—Rectal disorder—Octreotide—thymus cancer	0.0294	0.0294	CcSEcCtD
Bicalutamide—Anorectal disorder—Octreotide—thymus cancer	0.0275	0.0275	CcSEcCtD
Bicalutamide—Multiple fractures—Octreotide—thymus cancer	0.0248	0.0248	CcSEcCtD
Bicalutamide—Fracture—Octreotide—thymus cancer	0.0248	0.0248	CcSEcCtD
Bicalutamide—Intestinal obstruction—Octreotide—thymus cancer	0.0212	0.0212	CcSEcCtD
Bicalutamide—Influenza-like symptoms—Octreotide—thymus cancer	0.0202	0.0202	CcSEcCtD
Bicalutamide—Herpes zoster—Octreotide—thymus cancer	0.0192	0.0192	CcSEcCtD
Bicalutamide—Nephrolithiasis—Octreotide—thymus cancer	0.018	0.018	CcSEcCtD
Bicalutamide—Neoplasm malignant—Octreotide—thymus cancer	0.0169	0.0169	CcSEcCtD
Bicalutamide—Breast pain—Octreotide—thymus cancer	0.0165	0.0165	CcSEcCtD
Bicalutamide—Rectal haemorrhage—Octreotide—thymus cancer	0.016	0.016	CcSEcCtD
Bicalutamide—Phosphatase alkaline increased—Octreotide—thymus cancer	0.0144	0.0144	CcSEcCtD
Bicalutamide—Injection site reaction—Octreotide—thymus cancer	0.0143	0.0143	CcSEcCtD
Bicalutamide—Influenza like illness—Octreotide—thymus cancer	0.014	0.014	CcSEcCtD
Bicalutamide—Neuropathy—Octreotide—thymus cancer	0.0136	0.0136	CcSEcCtD
Bicalutamide—Cramps of lower extremities—Octreotide—thymus cancer	0.0133	0.0133	CcSEcCtD
Bicalutamide—Gynaecomastia—Octreotide—thymus cancer	0.0129	0.0129	CcSEcCtD
Bicalutamide—Thrombophlebitis—Octreotide—thymus cancer	0.0121	0.0121	CcSEcCtD
Bicalutamide—Blood alkaline phosphatase increased—Octreotide—thymus cancer	0.012	0.012	CcSEcCtD
Bicalutamide—Diabetes mellitus—Octreotide—thymus cancer	0.012	0.012	CcSEcCtD
Bicalutamide—Cardiac failure congestive—Octreotide—thymus cancer	0.0116	0.0116	CcSEcCtD
Bicalutamide—Hot flush—Octreotide—thymus cancer	0.0112	0.0112	CcSEcCtD
Bicalutamide—Menopausal symptoms—Octreotide—thymus cancer	0.0111	0.0111	CcSEcCtD
Bicalutamide—Arthritis—Octreotide—thymus cancer	0.0108	0.0108	CcSEcCtD
Bicalutamide—Hypoglycaemia—Octreotide—thymus cancer	0.0107	0.0107	CcSEcCtD
Bicalutamide—Dehydration—Octreotide—thymus cancer	0.00974	0.00974	CcSEcCtD
Bicalutamide—Dry skin—Octreotide—thymus cancer	0.0096	0.0096	CcSEcCtD
Bicalutamide—Gastritis—Octreotide—thymus cancer	0.00927	0.00927	CcSEcCtD
Bicalutamide—Muscular weakness—Octreotide—thymus cancer	0.00924	0.00924	CcSEcCtD
Bicalutamide—Influenza—Octreotide—thymus cancer	0.00906	0.00906	CcSEcCtD
Bicalutamide—Asthma—Octreotide—thymus cancer	0.00906	0.00906	CcSEcCtD
Bicalutamide—Bronchitis—Octreotide—thymus cancer	0.00871	0.00871	CcSEcCtD
Bicalutamide—Dysuria—Octreotide—thymus cancer	0.00847	0.00847	CcSEcCtD
Bicalutamide—Pollakiuria—Octreotide—thymus cancer	0.00837	0.00837	CcSEcCtD
Bicalutamide—Weight increased—Octreotide—thymus cancer	0.00824	0.00824	CcSEcCtD
Bicalutamide—Weight decreased—Octreotide—thymus cancer	0.00819	0.00819	CcSEcCtD
Bicalutamide—Hyperglycaemia—Octreotide—thymus cancer	0.00817	0.00817	CcSEcCtD
Bicalutamide—Pneumonia—Octreotide—thymus cancer	0.00812	0.00812	CcSEcCtD
Bicalutamide—Depression—Octreotide—thymus cancer	0.00805	0.00805	CcSEcCtD
Bicalutamide—Neuropathy peripheral—Octreotide—thymus cancer	0.00792	0.00792	CcSEcCtD
Bicalutamide—Jaundice—Octreotide—thymus cancer	0.00787	0.00787	CcSEcCtD
Bicalutamide—Conjunctivitis—Octreotide—thymus cancer	0.00785	0.00785	CcSEcCtD
Bicalutamide—Urinary tract infection—Octreotide—thymus cancer	0.00785	0.00785	CcSEcCtD
Bicalutamide—Haematuria—Octreotide—thymus cancer	0.0077	0.0077	CcSEcCtD
Bicalutamide—Hepatobiliary disease—Octreotide—thymus cancer	0.00764	0.00764	CcSEcCtD
Bicalutamide—Epistaxis—Octreotide—thymus cancer	0.00762	0.00762	CcSEcCtD
Bicalutamide—Sinusitis—Octreotide—thymus cancer	0.00758	0.00758	CcSEcCtD
Bicalutamide—Bradycardia—Octreotide—thymus cancer	0.00738	0.00738	CcSEcCtD
Bicalutamide—Rhinitis—Octreotide—thymus cancer	0.00727	0.00727	CcSEcCtD
Bicalutamide—Pharyngitis—Octreotide—thymus cancer	0.00719	0.00719	CcSEcCtD
Bicalutamide—Oedema peripheral—Octreotide—thymus cancer	0.00714	0.00714	CcSEcCtD
Bicalutamide—Visual impairment—Octreotide—thymus cancer	0.00699	0.00699	CcSEcCtD
Bicalutamide—Cardiac disorder—Octreotide—thymus cancer	0.00673	0.00673	CcSEcCtD
Bicalutamide—Immune system disorder—Octreotide—thymus cancer	0.00655	0.00655	CcSEcCtD
Bicalutamide—Arrhythmia—Octreotide—thymus cancer	0.00648	0.00648	CcSEcCtD
Bicalutamide—Alopecia—Octreotide—thymus cancer	0.00641	0.00641	CcSEcCtD
Bicalutamide—Mental disorder—Octreotide—thymus cancer	0.00635	0.00635	CcSEcCtD
Bicalutamide—Malnutrition—Octreotide—thymus cancer	0.00631	0.00631	CcSEcCtD
Bicalutamide—Flatulence—Octreotide—thymus cancer	0.00622	0.00622	CcSEcCtD
Bicalutamide—Tension—Octreotide—thymus cancer	0.00619	0.00619	CcSEcCtD
Bicalutamide—Nervousness—Octreotide—thymus cancer	0.00613	0.00613	CcSEcCtD
Bicalutamide—Back pain—Octreotide—thymus cancer	0.0061	0.0061	CcSEcCtD
Bicalutamide—Muscle spasms—Octreotide—thymus cancer	0.00607	0.00607	CcSEcCtD
Bicalutamide—Anaemia—Octreotide—thymus cancer	0.00583	0.00583	CcSEcCtD
Bicalutamide—Syncope—Octreotide—thymus cancer	0.00566	0.00566	CcSEcCtD
Bicalutamide—Loss of consciousness—Octreotide—thymus cancer	0.00555	0.00555	CcSEcCtD
Bicalutamide—Cough—Octreotide—thymus cancer	0.00551	0.00551	CcSEcCtD
Bicalutamide—Hypertension—Octreotide—thymus cancer	0.00545	0.00545	CcSEcCtD
Bicalutamide—Myalgia—Octreotide—thymus cancer	0.00537	0.00537	CcSEcCtD
Bicalutamide—Chest pain—Octreotide—thymus cancer	0.00537	0.00537	CcSEcCtD
Bicalutamide—Anxiety—Octreotide—thymus cancer	0.00535	0.00535	CcSEcCtD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00534	0.00534	CcSEcCtD
Bicalutamide—Dry mouth—Octreotide—thymus cancer	0.00525	0.00525	CcSEcCtD
Bicalutamide—Oedema—Octreotide—thymus cancer	0.00515	0.00515	CcSEcCtD
Bicalutamide—Infection—Octreotide—thymus cancer	0.00512	0.00512	CcSEcCtD
Bicalutamide—Shock—Octreotide—thymus cancer	0.00507	0.00507	CcSEcCtD
Bicalutamide—Nervous system disorder—Octreotide—thymus cancer	0.00505	0.00505	CcSEcCtD
Bicalutamide—Thrombocytopenia—Octreotide—thymus cancer	0.00504	0.00504	CcSEcCtD
Bicalutamide—Skin disorder—Octreotide—thymus cancer	0.005	0.005	CcSEcCtD
Bicalutamide—Hyperhidrosis—Octreotide—thymus cancer	0.00498	0.00498	CcSEcCtD
Bicalutamide—Anorexia—Octreotide—thymus cancer	0.00491	0.00491	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00469	0.00469	CcSEcCtD
Bicalutamide—Insomnia—Octreotide—thymus cancer	0.00466	0.00466	CcSEcCtD
Bicalutamide—Paraesthesia—Octreotide—thymus cancer	0.00462	0.00462	CcSEcCtD
Bicalutamide—Dyspnoea—Octreotide—thymus cancer	0.00459	0.00459	CcSEcCtD
Bicalutamide—Somnolence—Octreotide—thymus cancer	0.00458	0.00458	CcSEcCtD
Bicalutamide—Dyspepsia—Octreotide—thymus cancer	0.00453	0.00453	CcSEcCtD
Bicalutamide—Decreased appetite—Octreotide—thymus cancer	0.00448	0.00448	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Octreotide—thymus cancer	0.00445	0.00445	CcSEcCtD
Bicalutamide—Fatigue—Octreotide—thymus cancer	0.00444	0.00444	CcSEcCtD
Bicalutamide—Constipation—Octreotide—thymus cancer	0.0044	0.0044	CcSEcCtD
Bicalutamide—Pain—Octreotide—thymus cancer	0.0044	0.0044	CcSEcCtD
Bicalutamide—Feeling abnormal—Octreotide—thymus cancer	0.00424	0.00424	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Octreotide—thymus cancer	0.00421	0.00421	CcSEcCtD
Bicalutamide—Urticaria—Octreotide—thymus cancer	0.00409	0.00409	CcSEcCtD
Bicalutamide—Abdominal pain—Octreotide—thymus cancer	0.00407	0.00407	CcSEcCtD
Bicalutamide—Body temperature increased—Octreotide—thymus cancer	0.00407	0.00407	CcSEcCtD
Bicalutamide—Hypersensitivity—Octreotide—thymus cancer	0.00379	0.00379	CcSEcCtD
Bicalutamide—Asthenia—Octreotide—thymus cancer	0.00369	0.00369	CcSEcCtD
Bicalutamide—Pruritus—Octreotide—thymus cancer	0.00364	0.00364	CcSEcCtD
Bicalutamide—Diarrhoea—Octreotide—thymus cancer	0.00352	0.00352	CcSEcCtD
Bicalutamide—Dizziness—Octreotide—thymus cancer	0.00341	0.00341	CcSEcCtD
Bicalutamide—Vomiting—Octreotide—thymus cancer	0.00327	0.00327	CcSEcCtD
Bicalutamide—Rash—Octreotide—thymus cancer	0.00325	0.00325	CcSEcCtD
Bicalutamide—Dermatitis—Octreotide—thymus cancer	0.00324	0.00324	CcSEcCtD
Bicalutamide—Headache—Octreotide—thymus cancer	0.00323	0.00323	CcSEcCtD
Bicalutamide—Nausea—Octreotide—thymus cancer	0.00306	0.00306	CcSEcCtD
